|
MTPAP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.075640E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.038000E-03 |
| Normal-vs-Stage2 |
1.182160E-01 |
| Normal-vs-Stage3 |
5.983000E-01 |
| Normal-vs-Stage4 |
6.482800E-01 |
| Stage1-vs-Stage2 |
6.851200E-01 |
| Stage1-vs-Stage3 |
2.433000E-01 |
| Stage1-vs-Stage4 |
3.719400E-01 |
| Stage2-vs-Stage3 |
5.821800E-01 |
| Stage2-vs-Stage4 |
5.344000E-01 |
| Stage3-vs-Stage4 |
9.455400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.321900E-03 |
| Normal-vs-AfricanAmerican |
2.514100E-02 |
| Normal-vs-Asian |
6.364600E-01 |
| Caucasian-vs-AfricanAmerican |
8.770000E-01 |
| Caucasian-vs-Asian |
1.330230E-01 |
| AfricanAmerican-vs-Asian |
1.615040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.179760E-03 |
| Normal-vs-Female |
8.628400E-01 |
| Male-vs-Female |
3.716100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.936300E-02 |
| Normal-vs-Extreme_Weight |
8.790700E-04 |
| Normal-vs-Obese |
1.122760E-01 |
| Normal-vs-Extreme_Obese |
6.685200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.003800E-01 |
| Normal_Weight-vs-Obese |
5.752400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.908600E-01 |
| Extreme_Weight-vs-Obese |
1.342630E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.847000E-01 |
| Obese-vs-Extreme_Obese |
7.843200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.109400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.757360E-01 |
| Normal-vs-Age(61-80Yrs) |
1.260420E-03 |
| Normal-vs-Age(81-100Yrs) |
1.89025999999259E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.730000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.962440E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.633800E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.548500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.965000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.945500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.180200E-03 |
| Normal-VS-Type2 PRCC |
4.287800E-02 |
| Normal-VS-KIRP CIMP |
5.512800E-01 |
| Normal-VS-Unclassified PRCC |
1.870830E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.486800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.211500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.468600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.016400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.029600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.256800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.960700E-03 |
| Normal-vs-N1 |
9.077800E-01 |
| Normal-vs-N2 |
4.781600E-01 |
| N0-vs-N1 |
7.083600E-02 |
| N0-vs-N2 |
7.936000E-01 |
| N1-vs-N2 |
3.088200E-01 |
|
|
